Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.14%, DAX +0.31%, CAC40 +0.06%

Oct 14 ,2026

  • Synopsis

    • European equity market futures point to a positive open amidst mostly higher Asia equities Wednesday. South Korea up sharply, albeit recovering only a portion of yesterday's selloff. Hong Kong moderately firmer. Japan flat to higher, mainland China mixed and Australia lagging. Better complexion in regional tech following yesterday's widespread weakness, though China names mostly lower. Japan semis and Hang Seng Tech outperforming. South Korea names also tracking sharp gains. Follows somewhat softer overnight tech performance with SOX index down 0.23% (fifth straight decline) and US big tech mixed (Mag 7 mostly better). US contracts gaining after benchmarks were mostly lower in the cash session with Nasdaq lagging.

    • UK Business Secretary Jonathan Reynolds said the government will not put tariffs on Chinese vehicles in response to European demands for British tariffs on Chinese imports. IEA releases monthly oil market report. Chancellor Merz will deliver a government statement on the upcoming European Council meeting in the German Bundestag. Regular weekly UK PMQs at 12noon BST followed shortly after by opposition day debate (topic (s) tbc), whilst committee topics include Dunkelflaute (the simultaneous occurrence of darkness and a lull in wind activity) and the risks of electricity intermittency at 10:00 (tbc) and energy security and net zero at 15:00 (gov minister Fahnbulleh). EU's von der Leyen participates in the Tripartite Social Summit.

    • In central banks, ECB's Lagarde in on-stage conversation at 3:10BST at CNN Global Perspectives event. BOE's Breeden and Croatia central bank's Zigman panellist at 4:30BST at Bangkok Economic Festival. Bank of France's Moulin fireside chat at 4:45BST at IMF, same event as BOE's Bailey is a panellist at 6:30 BST and BOE's Pill fireside chat / Q+A at 7:00BST at Citi Roundtable. ECB's Lagarde in a conversation at 9:00BST at Atlantic Council at IMF, the same time as ECB's Elderson gives a speech at ECB-BoE Conf on Supervising Climate Risk in a Non-Linear World.

    • Macro data will include final Sep CPIs from Spain, Sweden and Finland.

    • Earnings include ASML (ASML.NA) reporting Q3 earnings and guiding Q4 and FY26 , while Lonza (LONN.SW) upgraded its organic growth model and mid-term financial ambitions ahead of CMD. Elsewhere in DACHs, Evotec (EVT.GR) reported preliminary nine-month results above expectations and PNE (PNE3.GR) cut its FY26 EBITDA guidance. In the Nordics, Aker BP (AKRBP.NO) reported Q3 production, while in the UK, Rio Tinto (RIO.LN) reported Q3 Pilbara iron ore shipments broadly in line with expectations.

    • Events include FT's Metals & Mining Summit (through Fri) including the Precious Metals Symposium on the first day if the conf. Fitch Rating event at 8:30CET on Western European Sovereigns. S&P Global Ratings Auto Industry Virtual Conf at 14:00BST.

  • Politics/Macro/World News

    • Bank of England's Bailey says companies are focusing on costs - Reuters

    • UK will not put tariffs on Chinese vehicles, says Jonathan Reynolds - Guardian

  • Top company news

    • Earnings/updates

      • Benelux:

        • ASML.NA (ASML Holding) -- reports Q3 net income €4.96B vs consensus €4.13B; guides Q4 and FY26

      • DACHs:

        • LONN.SW (Lonza Group) -- Lonza upgrades organic growth model and mid-term financial ambitions -- CMD

        • EVT.GR (Evotec) -- reports prelim nine-months 2026 results above market expectations; reaffirms FY 2026 guidance

        • SCMN.SW (Swisscom) -- Federal Administrative Court upheld Swisscom's appeal in fibre-optic court case and overturned COMCO decision including the CHF18M fine, FY26 financial outlook unchanged

        • BOSN.SW (Bossard Holding) -- reports Q3 revenue CHF296.1M vs FactSet CHF283M [1 est ]

        • PNE3.GR (PNE) -- guides FY26 normalized EBITDA €65-80M vs prior guidance €110-140M and FactSet €103.5M [4 est, €95.7-107.1M]

      • Nordics:

        • AKRBP.NO (Aker BP) -- reports Q3 net production 374.3 mboepd vs quarter-ago 383.6 mboepd

        • ONCO.SS (Oncopeptides) -- completes SEK100M share issue comprising 50M shares priced at SEK2.00/sh

        • KESKOB.FH (Kesko) -- reports September sales from continuing operations €1.19B, +4.3% in comparable terms

        • AVARDA.SS (Avarda Bank) -- reports Q3 adjusted EPS SEK3.51 vs year-ago SEK2.70

      • UK:

        • RIO.LN (Rio Tinto) -- reports Q3 production; Pilbara iron ore shipments (100% basis) 85.7Mt vs StreetAccount 85.5Mt

    • M&A

      • BYG.LN (Big Yellow Group) -- Activist fund Ancora reportedly pressing Big Yellow Group to explore potential sale -- Bloomberg

      • GALD.SW (Galderma Group) -- to acquire ZO Skin Health for an enterprise value of $1.5B

      • FNTN.GR (Freenet) -- acquires full ownership of waipu.tv for ~€76M, based on a company valuation of ~€300M

      • CE.IM (Credito Emiliano) -- CREDEM enters into exclusive talks with MCC for the acquisition of the controlling stake in BdM Banca

      • FGA.FP (Figeac Aero) -- acquires bodycote sud-Ouest; price undisclosed

      • C2PU.SP (Parkway Life REIT) -- to acquire three nursing home properties in France from DomusVi for €38.8M (~SG$56.5M)

      • Decagon evaluating acquisition interest, has held early talks with ServiceNow, others -- Business Insider

      • ServiceNow has no interest or intention of purchasing Decagon - tweet from @azvery (President, CPO, and COO Amit Zavery)

    • Healthcare

      • ABBV (AbbVie) -- presents new Ph3 AFFIRM data on SKYRIZI in patients with moderately to severely active Crohn's Disease

      • LONN.SW (Lonza Group) -- Trading halted in Lonza Group on SGX pending news release

      • ZEAL.DC (Zealand Pharma) -- and Generate Biomedicines team up to develop AI-driven obesity treatments in deal worth up to ~$1.2B

      • ONCO.SS (Oncopeptides) -- intends to carry out directed share issue of ~SEK100M

      • MEDCL.FP (MedinCell) -- announces additional €13.8M in non-dilutive financing

    • Other

      • FUR.NA (Fugro) -- enters into €150M unsecured financing facility with European Investment Bank to support ongoing development and deployment of uncrewed surface vessel technology

      • GLEN.LN (Glencore) -- Chess Depository Interests open at A$11.44 on the ASX

      • BBVA.SM (Banco Bilbao Vizcaya Argentaria) -- launches a second tranche of its share buyback programme for up to €1B

      • SHA0.GR (Schaeffler) -- Transcript Intelligence: Schaeffler Business Update Call

      • NEL.NO (NEL ASA) -- announces $12M purchase order

      • AVIO.IM (Avio) -- Lockheed Martin and Avio announce cooperation agreement for solid rocket motor production

      • APAC morning themes include Semis/Memory rebound ahead of ASML's Q3 earnings; Uranium lower on Paladin Q1 miss; Lithium firmer on Core Lithium BP33 update (14-Oct)

      • Guyana may curb LNG plans as Exxon needs more offshore gas for its wells than previously expected - Reuters, citing sources

      • Petrobras discloses update on AIP for Berbigão and Sururu Shared Reservoirs - 6-K

      • Quick Take: Rio Tinto trading (0.5%) as quarterly production broadly in line; lithium the main miss

  • Key rating changes

    • Upgrades

      • JPMorgan upgrades AAL.LN, AGL.SJ, GLEN.LN, others

      • BCP.PL (Banco Comercial Portugues) -- to buy from neutral at Goldman Sachs

      • PNN.LN (Pennon Group) -- to buy from hold at Jefferies

      • TE.FP (Technip Energies) -- to buy from neutral at UBS

    • Downgrades

      • SREN.SW (Swiss Re) -- to underperform from hold at Jefferies

      • GET.FP (Getlink) -- to hold from buy at Kepler Cheuvreux

    • Initiations

      • WIE.AV (Wienerberger) -- hold at Jefferies

  • Data

    • Nikkei +0.48% to 68105.06

    • Hang Seng +0.70% to 24515.54

    • Shanghai Composite (0.26%) to 3791.17

    • S&P futures +11.5 vs prior close of 7855.8

    • €-$ +0.0006 or +0.05% to 1.1207

    • $-¥ (0.01) or (0.01%) to 158.31

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.